Nifty
:
22567.55
Sensex
:
74425.30
165.15 (0.74%)
572.36 (0.77%)
Nifty
Sensex
:
:
22567.55
74425.30
165.15 (0.74%)
572.36 (0.77%)

Bal Pharma Ltd.

Pharmaceuticals & Drugs

Rating :
51/99

BSE: 524824 | NSE: BALPHARMA

NSE BSE
100.60
24-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  101.00
  •  103.95
  •  100.00
  •  101.25
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6289
  •  6.37
  •  132.45
  •  77.50

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 159.47
  • 45.32
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 292.16
  • 0.99%
  • 2.48

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.23%
  • 0.52%
  • 32.15%
  • FII
  • DII
  • Others
  • 0.13%
  • 0.00%
  • 15.97%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 5.45
  • 6.22
  • 6.69

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.52
  • 7.39
  • 0.48

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -6.57
  • -7.48
  • -18.46

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 37.24
  • 27.68
  • 37.47

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.99
  • 1.98
  • 2.52

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.95
  • 11.61
  • 10.22

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
81.66
76.62
6.58%
92.54
75.31
22.88%
70.39
69.84
0.79%
82.45
74.05
11.34%
Expenses
73.87
70.47
4.82%
84.84
69.53
22.02%
63.94
64.81
-1.34%
74.29
70.60
5.23%
EBITDA
7.80
6.15
26.83%
7.70
5.77
33.45%
6.44
5.03
28.03%
8.16
3.45
136.52%
EBIDTM
9.55%
8.03%
8.32%
7.67%
9.16%
7.21%
9.90%
4.65%
Other Income
0.10
0.46
-78.26%
0.14
0.05
180.00%
0.16
0.24
-33.33%
0.19
3.70
-94.86%
Interest
3.66
3.11
17.68%
3.82
2.86
33.57%
3.64
2.37
53.59%
3.85
2.45
57.14%
Depreciation
2.96
2.45
20.82%
2.42
2.37
2.11%
2.53
2.23
13.45%
2.09
2.42
-13.64%
PBT
1.27
1.05
20.95%
1.60
0.60
166.67%
0.43
0.68
-36.76%
2.41
2.28
5.70%
Tax
0.42
0.46
-8.70%
0.63
0.47
34.04%
0.34
0.40
-15.00%
0.79
0.09
777.78%
PAT
0.85
0.59
44.07%
0.97
0.13
646.15%
0.10
0.28
-64.29%
1.62
2.19
-26.03%
PATM
1.04%
0.77%
1.05%
0.17%
0.14%
0.41%
1.96%
2.95%
EPS
0.56
0.37
51.35%
0.60
0.07
757.14%
0.05
0.19
-73.68%
1.02
1.33
-23.31%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
327.04
304.22
281.21
250.53
171.09
225.01
209.29
228.91
198.32
187.16
178.87
Net Sales Growth
10.55%
8.18%
12.25%
46.43%
-23.96%
7.51%
-8.57%
15.42%
5.96%
4.63%
 
Cost Of Goods Sold
183.08
158.95
155.74
140.87
75.74
104.04
88.57
103.94
94.06
87.49
83.74
Gross Profit
143.96
145.27
125.48
109.66
95.35
120.96
120.71
124.97
104.25
99.67
95.14
GP Margin
44.02%
47.75%
44.62%
43.77%
55.73%
53.76%
57.68%
54.59%
52.57%
53.25%
53.19%
Total Expenditure
296.94
278.97
257.24
225.88
166.07
207.33
191.95
214.10
183.46
170.05
161.00
Power & Fuel Cost
-
7.73
5.89
4.98
4.76
6.38
6.07
6.17
4.66
4.54
4.39
% Of Sales
-
2.54%
2.09%
1.99%
2.78%
2.84%
2.90%
2.70%
2.35%
2.43%
2.45%
Employee Cost
-
55.30
47.25
41.88
50.44
50.28
52.16
45.37
37.30
32.24
28.12
% Of Sales
-
18.18%
16.80%
16.72%
29.48%
22.35%
24.92%
19.82%
18.81%
17.23%
15.72%
Manufacturing Exp.
-
27.76
21.92
18.62
15.80
20.28
18.03
21.44
19.80
20.78
18.23
% Of Sales
-
9.12%
7.79%
7.43%
9.23%
9.01%
8.61%
9.37%
9.98%
11.10%
10.19%
General & Admin Exp.
-
10.16
8.07
5.47
7.48
9.27
11.21
16.82
13.98
12.43
11.54
% Of Sales
-
3.34%
2.87%
2.18%
4.37%
4.12%
5.36%
7.35%
7.05%
6.64%
6.45%
Selling & Distn. Exp.
-
16.36
14.86
10.28
10.61
15.74
15.63
19.50
13.18
11.91
13.49
% Of Sales
-
5.38%
5.28%
4.10%
6.20%
7.00%
7.47%
8.52%
6.65%
6.36%
7.54%
Miscellaneous Exp.
-
2.72
3.51
3.79
1.23
1.33
0.27
0.86
0.47
0.65
13.49
% Of Sales
-
0.89%
1.25%
1.51%
0.72%
0.59%
0.13%
0.38%
0.24%
0.35%
0.83%
EBITDA
30.10
25.25
23.97
24.65
5.02
17.68
17.34
14.81
14.86
17.11
17.87
EBITDA Margin
9.20%
8.30%
8.52%
9.84%
2.93%
7.86%
8.29%
6.47%
7.49%
9.14%
9.99%
Other Income
0.59
0.94
5.15
1.14
1.85
1.01
1.73
3.04
1.28
1.17
0.65
Interest
14.97
12.31
10.91
12.16
12.73
12.74
9.41
8.49
6.48
6.52
7.16
Depreciation
10.00
9.13
9.04
9.52
7.68
6.16
6.77
6.49
7.01
7.02
4.74
PBT
5.71
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
Tax
2.18
2.13
3.48
-0.61
-0.64
-2.36
2.51
3.27
2.39
1.19
1.55
Tax Rate
38.18%
44.84%
37.91%
-14.88%
4.73%
1180.00%
87.15%
113.94%
90.19%
25.11%
23.38%
PAT
3.54
2.57
5.61
4.74
-12.22
3.79
2.79
1.75
1.41
3.62
5.07
PAT before Minority Interest
3.53
2.62
5.70
4.71
-12.89
2.15
0.38
-0.40
0.26
3.55
5.07
Minority Interest
-0.01
-0.05
-0.09
0.03
0.67
1.64
2.41
2.15
1.15
0.07
0.00
PAT Margin
1.08%
0.84%
1.99%
1.89%
-7.14%
1.68%
1.33%
0.76%
0.71%
1.93%
2.83%
PAT Growth
10.97%
-54.19%
18.35%
-
-
35.84%
59.43%
24.11%
-61.05%
-28.60%
 
EPS
2.24
1.63
3.55
3.00
-7.73
2.40
1.77
1.11
0.89
2.29
3.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
63.79
58.63
53.58
52.43
66.64
64.99
62.45
54.90
55.20
50.05
Share Capital
15.69
14.82
14.82
14.17
14.17
14.17
14.17
12.87
12.87
11.11
Total Reserves
48.10
42.87
37.82
38.25
52.47
50.82
48.27
40.01
40.31
37.20
Non-Current Liabilities
37.97
36.40
34.19
33.56
37.85
45.57
30.02
45.12
16.34
17.92
Secured Loans
30.52
27.01
23.93
22.93
28.76
33.25
12.76
15.24
6.11
6.58
Unsecured Loans
0.00
0.00
0.00
0.22
0.00
1.43
5.04
19.71
0.53
1.39
Long Term Provisions
5.07
4.69
4.07
3.62
2.71
2.05
3.42
2.28
1.65
1.06
Current Liabilities
209.33
165.65
152.53
159.49
163.24
154.40
143.24
111.19
92.36
86.77
Trade Payables
78.92
65.56
47.17
38.67
47.34
49.96
54.43
46.85
38.53
33.53
Other Current Liabilities
31.05
24.21
23.57
30.69
27.86
33.77
16.45
12.01
11.86
8.66
Short Term Borrowings
92.72
70.75
80.82
89.63
87.08
68.31
71.07
50.09
40.14
42.75
Short Term Provisions
6.64
5.12
0.98
0.50
0.96
2.37
1.29
2.24
1.83
1.83
Total Liabilities
311.00
260.55
240.07
238.38
261.31
260.17
233.33
211.03
163.87
154.74
Net Block
76.46
67.39
68.59
70.71
70.39
71.48
59.98
56.23
52.20
55.18
Gross Block
127.10
111.45
105.10
97.70
89.76
84.71
66.44
106.10
95.14
90.11
Accumulated Depreciation
50.64
44.06
36.52
27.00
19.37
13.23
6.46
49.87
42.95
34.93
Non Current Assets
82.85
75.96
75.93
81.02
78.26
75.41
68.78
68.03
58.74
59.63
Capital Work in Progress
0.00
1.61
0.00
3.32
3.63
0.21
1.70
3.93
0.77
0.25
Non Current Investment
0.00
0.00
0.00
0.00
0.02
0.02
0.02
0.02
0.02
0.02
Long Term Loans & Adv.
4.61
5.01
4.86
5.43
1.69
3.15
6.61
7.54
5.42
3.95
Other Non Current Assets
1.78
1.95
2.49
1.56
2.54
0.55
0.46
0.32
0.34
0.24
Current Assets
228.16
184.57
164.15
157.37
183.05
184.77
164.55
143.00
105.12
95.12
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
98.00
74.40
60.39
67.71
69.75
66.49
54.73
41.75
35.82
31.71
Sundry Debtors
93.98
75.31
67.20
49.60
64.70
64.05
61.80
56.94
44.98
45.49
Cash & Bank
7.61
5.39
3.85
3.13
4.32
4.15
4.71
4.63
5.49
3.02
Other Current Assets
28.56
12.49
4.69
4.07
44.28
50.07
43.31
39.66
18.83
14.89
Short Term Loans & Adv.
24.83
16.98
28.02
32.85
43.58
49.83
42.45
38.45
17.48
13.96
Net Current Assets
18.82
18.93
11.61
-2.12
19.81
30.36
21.31
31.81
12.77
8.35
Total Assets
311.01
260.53
240.08
238.39
261.31
260.18
233.33
211.03
163.86
154.75

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
-1.84
26.80
22.34
23.24
7.76
0.58
6.31
-19.35
14.53
13.31
PBT
4.75
9.18
4.10
-13.53
-0.20
2.88
2.87
2.65
4.74
6.63
Adjustment
21.44
17.15
21.14
19.01
17.41
15.14
14.79
11.46
11.69
10.43
Changes in Working Capital
-27.52
1.66
-2.80
17.94
-7.07
-16.18
-9.95
-32.66
-0.59
-2.59
Cash after chg. in Working capital
-1.34
28.00
22.45
23.42
10.13
1.84
7.72
-18.55
15.84
14.47
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-0.50
-1.20
-0.11
-0.17
-2.38
-1.27
-1.40
-0.80
-1.31
-1.16
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-22.18
-9.48
-5.53
-4.71
-8.04
-3.56
-7.96
-13.88
-5.30
-7.30
Net Fixed Assets
-13.94
-7.15
-3.66
-6.22
-4.61
-3.80
41.86
-12.93
-5.24
-15.62
Net Investments
0.00
0.00
-0.98
0.02
0.00
-7.42
1.16
-0.09
-1.07
0.04
Others
-8.24
-2.33
-0.89
1.49
-3.43
7.66
-50.98
-0.86
1.01
8.28
Cash from Financing Activity
24.40
-17.22
-16.63
-19.97
0.01
3.53
-5.94
32.37
-6.80
-7.52
Net Cash Inflow / Outflow
0.37
0.09
0.17
-1.44
-0.27
0.55
-7.58
-0.86
2.43
-1.51
Opening Cash & Equivalents
1.11
1.02
0.86
2.44
2.71
2.16
-17.72
5.49
3.02
4.53
Closing Cash & Equivalent
1.49
1.11
1.02
0.86
2.44
2.71
-25.30
4.63
5.45
3.02

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
40.66
38.92
35.52
36.99
47.02
45.86
44.06
41.09
41.32
43.48
ROA
0.92%
2.28%
1.97%
-5.16%
0.83%
0.15%
-0.18%
0.14%
2.23%
3.50%
ROE
4.31%
10.34%
8.97%
-21.65%
3.27%
0.59%
-0.69%
0.49%
7.00%
12.03%
ROCE
9.56%
12.33%
9.72%
-0.44%
6.88%
7.45%
7.59%
7.35%
10.88%
14.05%
Fixed Asset Turnover
2.55
2.60
2.47
1.83
2.58
2.80
2.72
2.01
2.06
2.18
Receivable days
101.56
92.48
85.08
121.92
104.42
108.60
92.23
91.87
86.58
82.73
Inventory Days
103.42
87.47
93.31
146.63
110.50
104.61
74.94
69.91
64.63
64.10
Payable days
165.90
132.11
111.21
90.28
86.70
99.47
88.16
89.31
79.05
72.93
Cash Conversion Cycle
39.08
47.85
67.18
178.27
128.22
113.74
79.02
72.47
72.17
73.90
Total Debt/Equity
2.05
1.80
2.09
2.26
1.85
1.69
1.49
1.68
0.93
1.08
Interest Cover
1.39
1.84
1.34
-0.06
0.98
1.31
1.34
1.41
1.73
1.93

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012

News Update:


  • Bal Pharma - Quarterly Results
    12th Feb 2024, 18:00 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.